Nestlé, DBV collaborate to develop patch-test tool to detect CMPA in infants
date:Jun 01, 2016
althy development, alleviate the anxieties of parents, and reduce healthcare costs.

Our reach in the field of pediatric allergy makes Nestl Health Science an ideal commercialization partner for DVB's innovative diagnostic patch. This collaboration is another step in our strategy of advancing the role of nutrition through science-based innovation.

DBV Technology CEO Dr. Pierre-Henri Benhamou said: Combining DBV's innovative and proprietary technology with Nestl Health Science's global presence
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
01/04 12:40